SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global medical nutrition market is estimated to be valued at US$ 12.2 billion in 2020 and is expected to exhibit a CAGR of 5.5% during the forecast period (2020-2027).
Key Trends and Analysis:
Key trends in the market are the increasing prevalence of chronic diseases, development and launch of medical nutrition products, and strategic mergers and collaborations among key players.
Key players are focusing on development of medical nutrition products to enhance their product portfolio and market presence, which is expected to drive growth of the medical nutrition market during the forecast period. For instance, in April 2016, Abbott Laboratories launched Ensure Enlive with Hydroxymethylbutyrate (HMB) and high protein. It is an advanced nutrition shake for older adults aged 40 and above. The drink reduces loss of muscle mass. The drink contains proteins, omega fatty acids, prebiotic fiber, and Vitamin D, C and E.
Moreover, key players are focusing on strategic collaborations which is expected to propel the market growth during the forecast period. For instance, in February 2020, Nestlé Health Science and Valbiotis (FR0013254851 – ALVAL/ PEA/SME eligible), a research and development company, entered a strategic partnership for the development and commercialization of TOTUM-63, an innovative and patented product to reduce the risk of developing type 2 diabetes in prediabetes.
Request for Sample PDF copy @ https://www.coherentmarketinsights.com/insight/request-sample/925
Key Market Takeaways:
The global medical nutrition market is expected to exhibit a CAGR of 5.5% during the forecast period owing to acquisitions by major players. For instance, in November 2019, DSM acquired AVA, a Boston (U.S.) based personalized nutrition platform that provides nutrition and coaching recommendations across a wide range of health and wellness segments. This acquisition has helped DSM expand its dietary supplement as well as food and beverage portfolio.
Among regions, North America is expected to hold a dominant position in the global market during the forecast period owing to the presence of key players such as Abbott and Baxter, and the rising number of product launch by regulatory authorities. For instance, in May 2019, Baxter International Inc., launched Clinolipid (20% Lipid Injectable Emulsion), its proprietary olive oil-based lipid emulsion, in the U.S. The announcement was made at the 2019 ASPEN Nutrition Science & Practice Conference, where Baxter featured its diverse portfolio of parenteral nutrition (PN) products to focus on and help improve care for malnourished patients.
Competitive Landscape—
Abbott, Baxter, Danone S.A., Nestlé, GlaxoSmithKline Plc, Fresenius Kabi AG, Sun Pharmaceuticals Inc., BASF SE and DSM among others.
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/925
Market Segmentation:
-
Global Medical Nutrition Market, By Nutrition Type:
- Proteins
- Carbohydrates
- Multi-Vitamins and Antioxidants
- Amino Acid
- Fibers
- Minerals
- Others
- Global Medical Nutrition Market, Patient Type:
- Infant Nutrition
- Adult Nutrition
- Geriatric Nutrition
- Global Medical Nutrition Market, By Indication:
- Diabetes
- Cancer
- Gastrointestinal Diseases
- Metabolic Syndromes
- Others
- Global Medical Nutrition Market, By Route of Administration:
- Oral
- Enteral
- Parenteral
- Global Medical Nutrition Market, By End User:
- Hospitals
- Home Care Settings
- Long Term Care
- Ambulatory Surgical Centers
-
Global Medical Nutrition Market, By Region:
-
North America
- U.S.
- Canada
-
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
-
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
-
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
-
Middle East
- GCC
- Israel
- Rest of Middle East
-
Africa
-
By Country/Region:
- South Africa
- Central Africa
- North Africa
-
By Country/Region:
-
North America
Related Market Intelligence Report:
U.S. Medical Foods Market, by Food Type (Prebiotics, Probiotics, and Food Supplements), by Disease Indication (Inflammatory Bowel Disease, Irritable Bowel Syndrome, and Others), and by Distribution Channel (Hospitals, Retail Channel, and Online Channel) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
Read more: https://www.coherentmarketinsights.com/market-insight/us-medical-foods-market-3215
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.
